<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02374749</url>
  </required_header>
  <id_info>
    <org_study_id>P140401</org_study_id>
    <nct_id>NCT02374749</nct_id>
  </id_info>
  <brief_title>COMorbidities and EDucation in SPondyloArthritis Study</brief_title>
  <acronym>COMEDSPA</acronym>
  <official_title>COmorbidities and EDucation in SpondyloArthritis Study (COMEDSPA) Evaluation of Standardized Follow-up in Axial Spondyloarthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - H么pitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - H么pitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Giving both the gap existing between the current recommendations to prevent/detect
      comorbidities and the clinical practice in patients suffering from spondyloarthritis and also
      the specificity of some recommendations to rheumatic diseases, it seems logical to check
      these recommendations in a rheumatologic &quot;environment&quot;.

      This study with its two parts should be able to demonstrate:

        -  The importance of a systematic evaluation of comorbidities in Spondyloarthritis,

        -  The utility of a nurse-led program of self-assessment and self-management of the disease
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with spondyloarthritis will be invited by their rheumatologists to participate at
      this study in 21 centers in France.

      500 patients are planned to be included.

      After written informed consent will be obtained, the patients will be randomized in two arms:

        -  comorbidities

        -  self-assessment/self-management The patients will be seen again in the same center 12
           months later in order to collect the outcome measures

      The two primary objectives of this trial are :

        -  To evaluate the impact of a nurse led program of self-assessment of disease
           activity/severity and self-management on the level of satisfaction/coping

        -  To evaluate the impact of a nurse led program of assessment of comorbidities on the
           management of such comorbidities

      The Secondary objectives are:

        -  To evaluate the prevalence of comorbidities in SpA;

        -  To evaluate the level of adherence to recommendations of prevention of comorbidities;

        -  To evaluate the impact of the nurse led program of self-assessment / self-management on
           the amount of NSAID (Non-steroidal Anti-Inflammatory Drugs) intake and the level of
           disability (e.g. functional disability)
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 23, 2015</start_date>
  <completion_date type="Actual">October 16, 2017</completion_date>
  <primary_completion_date type="Actual">October 16, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comorbidities</measure>
    <time_frame>1 year later</time_frame>
    <description>Changes after 12 months in the comorbidity composite score. Such composite score has been established prior the study and is taking into account the optimal management of patients (e.g. Normal blood pressure, no smoking,....) . Such score will be calculated at baseline and at the one year visit in the two groups.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>self-assessment/self-management</measure>
    <time_frame>1 year later</time_frame>
    <description>The level of coping after 12 months based on the question#8 ( 0-10 NRS) of the RAID score. Such outcome will be evaluated at both the baseline and the one year visits in both groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Frequency of comorbidities in Spondyloarthritis</measure>
    <time_frame>1 year later</time_frame>
    <description>This analysis will be purely descriptive and will include the percentage of patients with:
History of cardiovascular diseases
Hypertension
Diabetes
Hyperlipidemia
History of skin cancer, colon, uterus, breast, prostate
Percentage of patients at high risk of cancers when these risks are known (eg, family history of breast cancer, colon)
History of tuberculosis, HIV, or hospitalization for severe infections.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of compliance with general recommendations on vaccinations, screening for certain cancers and osteoporosis screening</measure>
    <time_frame>1 year later</time_frame>
    <description>The percentage of patients adhering to these recommendations will be assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact of self-assessment by the patient of his/her Spondyloarthritis activity (ASDAS-CRP (C Reactive Protein), BASDAI) on the activity and severity of the disease</measure>
    <time_frame>1 year later</time_frame>
    <description>The final value of BASDAI and ASDAS-CRP will be compared in the two groups of patients by adjusting the analysis of the initial value.
The final visit BASFI value will be compared in the two groups of patients by adjusting the analysis of the initial value</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient compliance program self-management of Spondyloarthritis</measure>
    <time_frame>1 year later</time_frame>
    <description>Compliance will be assessed by the percentage of the collections of the disease activity (BASDAI, ASDAS-CRP) actually made by the patient with regard the theoretical number one (e.g. monthly).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">503</enrollment>
  <condition>Axial Spondyloarthritis</condition>
  <arm_group>
    <arm_group_label>comorbidities</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Evaluation of the prevalence and the presence of the risks factors of the four most frequently observed comorbidities in spondyloarthritis (cardiovascular diseases, cancers, infections osteoporosis and gastro-intestinal) as it is recommended by the French Society of Rheumatology.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>self-assessment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>During the initial visit, the clinical research nurse exempt a learning program of assessment of disease activity/severity :
for assessing the activity in SpA;
for the calculation of BASDAI and the ASDAS-CRP
for the transfer technique and for the calculation of the disease activity on a monthly basis during the next 12 months.
for the risk of tobacco exposure
for the benefit of an NSAID intake in case of painful episode of the disease
for the benefit of home exercises
for the spine and indication of a treatment under the supervision of a physiotherapist in case of severe disease
for learning the patient to calculate his BASDAI and ASDAS-CRP Then, the patient will return home with his calculator and his notebook. Each month, the patient will be asked to perform the BASDAI and ASDAS-CRP calculations and to report the data on the notebook. 12 months later, the patient comes for a visit in the current practice to assess both such program and comorbidities.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>self-assessment/self-management</intervention_name>
    <description>Nurse led-program of self-assessment/ self-management of spondyloarthritis</description>
    <arm_group_label>self-assessment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Comorbidities (detection/prevention)</intervention_name>
    <description>Standardized assessment of comorbidities by nurses</description>
    <arm_group_label>comorbidities</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female over 18 and under 80 years

          2. Axial Spondyloarthritis according to the ASAS criteria (Assessment of
             SpondyloArthritis international Society)

          3. Disease duration of at least one year

          4. Activity of SpA to be stable according to the treating rheumatologist for at least
             three months before the date of inclusion

          5. Lack of elective surgery during the 6 months after inclusion

          6. Able to understand and adhere to the study treatments

          7. Development of a medical examination results given to the patient

          8. Informed Consent signed and dated

        Exclusion Criteria:

          1. Pregnant women (any method of contraception will be accepted)

          2. Patients who have had a change in the treatment of SpA during the 3 months prior to
             inclusion

          3. History of alcoholism, drug addiction, psychological problems, severe comorbidities
             that could possibly invalidate informed consent or limit patient compliance with the
             study protocol

          4. No affiliation to a social security regime
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maxime DOUGADOS, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - H么pitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>H么pital Cochin</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 1, 2015</study_first_submitted>
  <study_first_submitted_qc>February 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 2, 2015</study_first_posted>
  <last_update_submitted>November 17, 2017</last_update_submitted>
  <last_update_submitted_qc>November 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Axial Spondyloarthritis</keyword>
  <keyword>Education</keyword>
  <keyword>Co-morbidities</keyword>
  <keyword>Nurse</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spondylarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

